Dr. Peng Dai serves as Executive Director of the R&D department for Asymchem Boston Corporation. His core responsibilities are establishing and managing the R&D center, collaborating with external partners, and fostering market development. Previously, he worked at another CDMO and a biopharma company, where he gained experience in innovative drug discovery and development, chemical process development, API manufacture, and project and team management. Dr. Dai received his BS in polymer chemistry and physics from the University of Science and Technology of China (USTC) and his Ph.D. in organic chemistry from University of Nebraska-Lincoln in 2004. He conducted postdoctoral research at the University of Nebraska-Lincoln and NIH center at Boston University and has more than 10 publications in peer-reviewed journals.